Home Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance
Article
Licensed
Unlicensed Requires Authentication

Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance

  • Aldo Clerico EMAIL logo , Simona Vittorini and Claudio Passino
Published/Copyright: August 26, 2011

Abstract

Recent studies demonstrated that large amounts of the pro-hormone peptide of brain natriuretic peptide (proBNP) can be detected in plasma of healthy subjects and in particular of patients with heart failure. As a result, a great part of B-type natriuretic peptides measured in patients with cardio-vascular disease may be devoid of biological activity. These findings stimulated the set up of specific immunoassay methods for the measurement of the intact proBNP peptide. The aim of this review article is to discuss the methodological characteristics and the possible clinical relevance of specific immunoassay methods for the measurement of the proBNP peptide. From an analytical point of view, a fully automated immunoassay of proBNP has some theoretical advantages (e.g., a more stable molecule with higher molecular weight than the derived peptides) compared to the active hormone BNP. Recent studies supported the concept that the precursor proBNP might be actually considered a circulating prohormone, which can be cleaved by specific plasma proteases in BNP, the active hormone, and NT-proBNP, an inactive peptide. The peripheral processing of circulating proBNP could likely be submitted to regulatory rules, which might be impaired in patients with heart failure, opening new perspectives in the treatment of heart failure (e.g., by studying drugs inducing the cleavage of the prohormone into active BNP). Furthermore, as a future perspective, the specific assay in the same plasma sample of the intact precursor proBNP and of the biologically active peptide BNP, could allow a more accurate estimation of the production/secretion of B-type related peptides from cardiomyocytes and of the global cardiac endocrine function.


Corresponding author: Prof. Aldo Clerico, MD, Department of Laboratory Medicine, Fondazione G. Monasterio CNR-Regione Toscana, Via Giuseppe Moruzzi 1, 56124 Pisa, Italy Phone: +39-0585-493569, Fax: +39-0585-493652

Received: 2011-5-9
Accepted: 2011-7-26
Published Online: 2011-8-26
Published in Print: 2011-12-1

©2011 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Editorial
  2. Appropriate labelling of blood collection tubes: a step ahead towards patient’s safety
  3. Reviews
  4. New insights into adipose tissue dysfunction in insulin resistance
  5. Role of biomarkers in cardioncology
  6. Minireviews
  7. Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance
  8. High-sensitivity troponin assays in the evaluation of patients with acute chest pain in the emergency department
  9. Opinion Paper
  10. Regulation of in vitro diagnostics (IVDs) for use in clinical diagnostic laboratories: towards the light or dark in clinical laboratory testing?
  11. Guidelines and Recommendations
  12. The Greek way to the Register: the establishment and operation of the Register for Clinical Chemists-Clinical Biochemists in Greece
  13. Genetics and Molecular Diagnostics
  14. Rapid HLA-B27 screening with real-time TaqMan PCR: a clinical validation in the Dutch population
  15. General Clinical Chemistry and Laboratory Medicine
  16. Results of the recalibration of creatinine measurement with the modular Beckman Coulter® Jaffe creatinine method
  17. Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera
  18. Oxidative status in the lungs associated with tobacco smoke exposure
  19. Correlation of cortisol in 1-cm hair segment with salivary cortisol in human: hair cortisol as an endogenous biomarker
  20. Evaluation of the MassTrak Immunosuppressant XE Kit for the determination of everolimus and cyclosporin A in human whole blood employing isotopically labeled internal standards
  21. Simultaneous determination of cyclophosphamide and 4-hydroxycyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry – application to Chinese systemic lupus erythematosus patients
  22. Sterol profiles in plasma and erythrocyte membranes in patients with Smith-Lemli-Opitz syndrome: a six-year experience
  23. Chemistry and haematology sample rejection and clinical impact in a tertiary laboratory in Cape Town
  24. Trefoil factor family peptides are increased in the saliva of children with mucositis
  25. Validation of commercial assays for measurements of trefoil factor family peptides in serum
  26. To mix or not to mix venous blood samples collected in vacuum tubes?
  27. Rapid and simple IgG specific test for the exclusion of heparin induced thrombocytopenia (HIT)
  28. β-Thalassemia mutations in subjects with borderline HbA2 values: a pilot study in North India
  29. Cancer Diagnostics
  30. Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers
  31. The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses
  32. Infectious Diseases
  33. Measurement of granulocyte maturation may improve the early diagnosis of the septic state
  34. Cardiovascular Diseases
  35. Influence of hemolysis on troponin testing: studies on Beckman Coulter UniCel Dxl 800 Accu-TnI and overview of the literature
  36. Methylenetetrahydrofolate reductase C677T polymorphism and congenital heart disease: a meta-analysis
  37. Determination of asymmetric dimethyl arginine in human serum by liquid chromatography-tandem mass spectrometry: clinical application in hypertensive subjects
  38. Diabetes
  39. The optimal cut-points of HbA1c for detecting newly diagnosed diabetes and pre-diabetes in the Chinese population living in Sichuan
  40. Letters to the Editor
  41. Specimen labelling: before or after collection?
  42. Effect of storage conditions and freeze/thaw cycles on aquaporin-4 antibody (NMO-IgG) serum levels
  43. Comparison of vancomycin concentrations in blood and interstitial fluid: a possible model for less invasive therapeutic drug monitoring
  44. Acknowledgement
  45. Acknowledgement
Downloaded on 5.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2011.686/html
Scroll to top button